Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects movement. It is the second most common neurodegenerative disorder, after Alzheimer's disease. As healthcare professionals, understanding the pathophysiology, symptoms, diagnosis, and management of PD is crucial for providing optimal patient care.
PD is characterized by the degeneration of dopamine-producing neurons in the substantia nigra, a region of the brain that regulates movement. The loss of these neurons leads to a decrease in dopamine levels, resulting in motor symptoms such as tremor, rigidity, and bradykinesia. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction can also occur.
Diagnosis of PD is primarily based on clinical criteria. The cardinal motor symptoms are resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms, including depression, sleep disorders, and cognitive impairment, are increasingly recognized as significant contributors to disability. Neuroimaging can support the diagnosis but is not required.
Management of PD is primarily symptomatic. Levodopa, combined with a dopa-decarboxylase inhibitor, remains the most effective treatment for motor symptoms. Non-motor symptoms are managed based on individual patient needs. Deep brain stimulation and other surgical options can be considered in advanced cases.
Healthcare professionals play a vital role in managing PD. Early identification and management of symptoms can significantly improve the quality of life for patients. Regular monitoring for progression and complications is essential. Multidisciplinary care involving neurologists, physiotherapists, occupational therapists, and mental health professionals is often beneficial.
In conclusion, PD is a complex neurodegenerative disorder with a wide range of motor and non-motor symptoms. Understanding the disease process, clinical features, and management strategies are essential for healthcare professionals to provide comprehensive care to patients with PD.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation